title: Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.
authors.affiliation: Department of Oncology, Haukeland University Hospital, Bergen, Norway. half@helse-bergen.no
authors.forename: H
authors.initials: H
authors.lastname: Sørbye
authors.forename: B
authors.initials: B
authors.lastname: Westre
authors.forename: A
authors.initials: A
authors.lastname: Horn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D018278:Carcinoma, Neuroendocrine / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D010179:Pancreas / Q000000981:diagnostic imaging; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
chemical_list: D005047:Etoposide; D002945:Cisplatin